Nie masz uprawnień do wyświetlenia tego obiektu. Aby poprosić o dostęp do niego, wypełnij poniższe pola.
Krawczyk, Katarzyna
2016
Praca doktorska
The analysis of 226 patients, treated with MCL in Hematology Clinic UJCM between 1992-2013, was conducted. 1st line chemotherapy regimens were: CHOP +/- R in 50%, FC+/-R in 23% and intensive induction treatment with cytarabine in 20%. Consolidation with radioimmunotherapy was administered in 34 cases, in 47 – HDT/ASCT. MRD was regularly assessed with flow cytometry in 46 patients. In 75% molecular was detected. Pre-emptive treatment was conducted in 25 cases. 20 of these patients, were treated intensively in the first line, with HDT/ASCT consolidation. Fist line treatment results were: ORR in 71,68%, SD in 5,31%. MCL was refractory in 24,78 % of cases. Median PFS was 28,78 months and median OS 49,9. Treatment results were similar to data from multicenter trials. Survival depended on: type of 1st line treatment and risk factors – MPI. MRD follow-up with flow cytometry is effective in molecular relapse detection, its implementation has an impact on survival in MCL patients. Pre-emptive therapy is effective method of MRD (-) re-achieving (ORR 80%). The use of pre-emptive therapy has a strong impact on OS and PFS among MCL patients, especially in subgroup after consolidation with HDT/ASCT (5-cio letnie OS 100%, vs.65%, PFS 100% vs.45%).
Kraków
2 - studia doktoranckie
hematologia
Wydział Lekarski
Jurczak, Wojciech
oai:dl.cm-uj.krakow.pl:4111
ZB-124961
pol
tylko w bibliotece
16 mar 2023
24 sie 2016
6
0
http://dl.cm-uj.krakow.pl:8080/publication/4111
RDF
OAI-PMH
Nowakowska-Kopera, Alicja
Pawińska-Wąsikowska, Katarzyna
Zawada, Magdalena
Książek, Teofila
Styl cytowania: chicago-author-date iso690-author-date
Ta strona wykorzystuje pliki 'cookies'. Więcej informacji Rozumiem